Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists

Add time:07/22/2019    Source:sciencedirect.com

A novel series of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as RORγt inverse agonists was discovered. Binding mode analysis of a RORγt partial agonist (2c) revealed by co-crystal structure in RORγt LBD suggests that the inverse agonists do not directly interfere with the interaction between H12 and the RORγt LBD. Detailed SAR exploration led to identification of potent RORγt inverse agonists such as 3m with a pIC50 of 8.0. Selected compounds in the series showed reasonable activity in Th17 cell differentiation assay as well as low intrinsic clearance in mouse liver microsomes.

We also recommend Trading Suppliers and Manufacturers of (2-(TRIFLUOROMETHYL)THIAZOL-5-YL)METHANOL (cas 131748-97-5). Pls Click Website Link as below: cas 131748-97-5 suppliers

Prev:Novel stilbene analogues containing thiazole moiety: Synthesis, biological evaluation and docking study
Next:Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors)